CBD STTR FY18A Phase II Awards

Topic Title Company
CBD18A-001 Circulating Diagnostic Markers of Infectious Disease Pathovacs Incorporated
CBD18A-001 Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases CFD Research Corporation
CBD18A-002 Marburg Virus Prophylactic Medical Countermeasure Mapp Biopharmaceutical, Inc.
CBD18A-002 Marburg Virus Prophylactic Medical Countermeasure Flow Pharma, Inc.
Last Update: August 7, 2020